SCHEMBL4837175

SCHEMBL4837175

O=C1C2CC3C(=O)N(OS(=O)(=O)c4ccc(Cl)cc4)C(=O)C3CC2C(=O)N1OS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 3/20 0.50
HPGD P15428 2/20 0.50
PARL Q9H300 2/20 0.44
MMP2 P08253 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 2/20 0.40
VDR P11473 2/20 0.40
POLB P06746 1/20 0.40
HSD11B1 P28845 1/20 0.39
MAPT P10636 2/20 0.39
CYP3A4 P08684 2/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4831931 0.85 KMT2A (0.55) ALDH1A1KDM4EHPGDPARLMMP2
SCHEMBL4831944 0.85 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDPARLMMP2
SCHEMBL4837258 0.84 VDR (0.58) ALDH1A1KDM4EHPGDPARLMMP2
SCHEMBL4830039 0.84 PARL (0.44) ALDH1A1KDM4EHPGDPARLMMP2
SCHEMBL4832240 0.84 KDM4E (0.50) ALDH1A1KDM4EHPGDPARLMMP2
SCHEMBL4837033 0.83 PARL (0.64) ALDH1A1KDM4EHPGDPARLMMP2
SCHEMBL4826503 0.81 GAA (0.49) ALDH1A1PARLMMP2VDRHSD11B1
SCHEMBL4833933 0.80 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDPARLKMT2A
SCHEMBL4835211 0.80 TDP1 (0.41) ALDH1A1KDM4EHPGDPARLTDP1
SCHEMBL4829940 0.80 PARL (0.44) ALDH1A1PARLMMP2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 ALDH1A1 633/4885KDM4E 2501/4885HPGD 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.